Copper-64 SAR Bombesin in PSMA Negative Prostate Cancer (BOP)

Clinical trial NCT05613842 · COMPLETED

Trial details

NCT number: NCT05613842
Sponsor: St Vincent's Hospital, Sydney
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2022-08-09
Primary completion: 2023-06-06
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.